# Merck & Co., Inc. (MRK) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Merck & Co., Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MRK/mda/fy2025/): filed 2026-02-24; accession 0000310158-26-000063 (https://www.sec.gov/Archives/edgar/data/310158/000031015826000063/mrk-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MRK/mda/fy2024/): filed 2025-02-25; accession 0001628280-25-007732 (https://www.sec.gov/Archives/edgar/data/310158/000162828025007732/mrk-20241231.htm)
- [FY 2023 MD&A](/company/MRK/mda/fy2023/): filed 2024-02-26; accession 0001628280-24-006850 (https://www.sec.gov/Archives/edgar/data/310158/000162828024006850/mrk-20231231.htm)
- [FY 2022 MD&A](/company/MRK/mda/fy2022/): filed 2023-02-24; accession 0001628280-23-005061 (https://www.sec.gov/Archives/edgar/data/310158/000162828023005061/mrk-20221231.htm)
- [FY 2021 MD&A](/company/MRK/mda/fy2021/): filed 2022-02-25; accession 0000310158-22-000003 (https://www.sec.gov/Archives/edgar/data/310158/000031015822000003/mrk-20211231.htm)

Back to /company/MRK/